Trial Profile
A Single-Arm Trial, Open-label, Repeated, Long-term, Multi-center, A Phase IV Clinical Trial to Evaluate the Long-term Efficacy and Safety of Repeat Treatment With MEDITOXIN in Treatment of Glabella Line
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Glabellar lines
- Focus Therapeutic Use
- Sponsors Medytox
- 10 Feb 2020 Status changed from active, no longer recruiting to completed.
- 23 Sep 2017 New trial record